Heron Therapeutics Inc vs Nutrien Ltd — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Nutrien Ltd trades at $67.3 (market cap $32.05B). The key difference: Nutrien Ltd is far larger — about 521.4× Heron Therapeutics Inc's market cap, and Nutrien Ltd pays a 3.27% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | NTR | |
|---|---|---|
Market Cap | $61.47M | $32.05B |
Sector | Health | Basic Materials |
52-Week High | $1.49 | $83.94 |
52-Week Low | $0.32 | $53.64 |
Enterprise Value | $168.21M | $43.86B |
Dividend Yield | — | 3.27% |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →